XML 60 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 28, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation Expenses

The following table shows stock-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 28, 2020 and March 30, 2019:

 

 

 

Three Months Ended

 

(in thousands)

 

March 28, 2020

 

 

March 30, 2019

 

Cost of revenues

 

$

24

 

 

$

19

 

Research and development

 

 

(31

)

 

 

103

 

Sales and marketing

 

 

39

 

 

 

163

 

General and administrative

 

 

63

 

 

 

330

 

 

 

$

95

 

 

$

615

 

Summary of Stock Options

The following table summarizes stock options information during the three months ended March 28, 2020:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

Per Share

 

 

Aggregate

Intrinsic

Value

(thousands)

 

Outstanding as of December 28, 2019

 

 

1,383,552

 

 

$

6.11

 

 

 

 

 

Granted

 

 

51,000

 

 

$

2.27

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

Canceled or forfeited

 

 

(132,102

)

 

$

6.76

 

 

 

 

 

Outstanding as of March 28, 2020

 

 

1,302,450

 

 

$

5.89

 

 

$

 

Weighted Average Assumptions for Fair Value Estimate of Stock-Based Awards (Options)

The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock-based awards (options) with the following weighted average assumptions:

 

 

 

 

 

 

 

March 28, 2020

 

 

March 30, 2019

 

Average risk free interest rate

 

 

0.46

%

 

 

2.15

%

Expected life (in years)

 

4.55 years

 

 

4.55 years

 

Dividend yield

 

 

%

 

 

%

Average volatility

 

 

57

%

 

 

44

%

Summary of Stock Options Outstanding, Vested, Expected to Vest and Exercisable

Information regarding stock options outstanding, vested, expected to vest, and exercisable as of March 28, 2020 is summarized below:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic Value

(thousands)

 

Options outstanding

 

 

1,302,450

 

 

$

5.89

 

 

 

5.13

 

 

$

 

Options vested and expected to vest

 

 

1,131,040

 

 

$

6.09

 

 

 

4.98

 

 

$

 

Options exercisable

 

 

373,116

 

 

$

8.57

 

 

 

2.78

 

 

$

 

Restricted Stock Units

Information regarding the restricted stock units (“RSUs”) activity for the three months ended March 28, 2020 is summarized below:

 

 

 

Number

of Shares

 

Outstanding as of December 28, 2019

 

 

411,133

 

Restricted stock units granted

 

 

 

Restricted stock units released

 

 

(3,499

)

Restricted stock units forfeited

 

 

(95,785

)

Outstanding as of March 28, 2020

 

 

311,849